Fundamentals of Transplant and Cellular Therapy-Day 1 - Conditioning Regimens - Enduring Material - Credit offering period June 16, 2026 - December 31, 2026
Kiersten Mullen, PharmD, BCOP
*Transplant process/Prep regimens
Resources:
Dose adjustment for chronic kidney disease (Bodge MN, et al)
Dose adjustment for chronic hepatic impairment (Bodge MN, et al)
Does adjustment for obese patients (Bubalo J, et al)
Personalizing busulfan regimen (Palmer J, et al)
Target Audience
Physicians, nurses, pharmacists, and allied health care professionals who practice in hematological-medical units, skilled nursing facilities, home care, hospice, radiation oncology, surgical oncology, and/or cellular transplant
Learning Objectives
Discuss the purpose of conditioning chemotherapy in autologous and allogeneic hematopoietic stem cell transplant (HSCT)
Review commonly used conditioning regimens
Review chemotherapy agents used in hematopoietic stem transplantation (HSCT) conditioning regimens, including pharmacokinetics, side effects, monitoring and preventative measures for each agent
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Available Credit
- 0.75 AMA PRA Category 1 Credit™

Facebook
X
LinkedIn
Forward